The NIPT (Plus), Singleton is a non-invasive test used to screen for potential chromosomal abnormalities in the fetus, such as Down syndrome, by examining fetal DNA found in the mother's blood. This test is considered a modern and accurate option, typically performed early in the pregnancy, usually after the 10th week. A blood sample is collected from the mother and analyzed in a laboratory to detect any genetic changes that might indicate chromosomal issues. This test is safer compared to traditional tests like amniocentesis, as it does not involve inserting instruments into the uterus. NIPT can provide valuable information to parents about the health of the fetus, helping them make informed decisions about further monitoring and healthcare. It is recommended for singleton pregnancies, as it provides precise and reliable results that enhance the care of both mother and baby.